Vyne Therapeutics Inc. (VYNE)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 76
-0.01
-0.9115%
$
11.85M Market Cap
- P/E Ratio
- Div Yield
996,000 Volume
-1 Eps
$ 0.77
Previous Close Want to track VYNE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vyne Therapeutics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Jeffrey Gundlach DoubleLine Capital LP | 22,400 | $2.57M | $17,357.76 | -$2.55M | -99.32% |
| RS Richard Slavik Newbridge Financial Services Group Inc. | 10 | $3.35 | $7.68 | $4.33 | 129.25% |
| KJ Ken Joseph Braidwel LLP | 916,077 | $547,356.01 | $704,280 | $156,923.99 | 28.67% |
| AH Anders Hove Acorn Capital Advisors LLC | 1,425 | $2,251.5 | $1,097.11 | -$1,154.39 | -51.27% |
| LC Leslie Childs MB Levis & Associates LLC | 1,041 | $3,206 | $802.51 | -$2,403.49 | -74.97% |
